logo
Shocking way American Airlines staff 'left our dad to die' after he fell ill on long-haul flight

Shocking way American Airlines staff 'left our dad to die' after he fell ill on long-haul flight

Daily Mail​25-04-2025

A Kentucky family has accused American Airlines of ignoring their dad's medical distress and allowing him to catch his connection flight, which they claimed led to his death.
John William Cannon, 62, died two years ago this month after suffering a 'syncopal,' or fainting, event while traveling on the airline Kentucky to Colorado for his female partner's celebration of life ceremony in April 2023.
While deplaning in Texas, Cannon suffered the fainting event and was helped to the floor of the jet bridge, but was later released to catch his connection flight despite 'exhibiting concerning signs of medical distress,' the complaint, viewed by DailyMail.com, read.
The father was experiencing labored breathing and losing consciousness - symptoms the family said should have clued American Airline's employees to help Cannon further.
His son, Kyle, and the family's attorneys argue his death was the 'direct and proximate result of the negligence and fault of' the airline.
'The circumstances of this case represent a tangible manifestation of a corporate culture at American Airlines that prioritizes inaction over intervention,' lawyers Joseph LoRusso and Jessica McBryant told DailyMail.com.
'This ingrained culture, to which John Cannon tragically fell victim, underscores a systemic issue the family is determined to address, both in seeking justice for John and in advocating for broader organizational change.'
Kyle is seeking damages for his father having to go through 'conscious pain, suffering, mental anguish, loss of time and income, medical expenses, and other damages prior to his death,' People reported.
The Cannon family is seeking $75,000 in damages, plus attorney fees.
American Airlines said in a statement to DailyMail.com: 'We are reviewing the complaint.'
Cannon died of a heart attack while paramedics were taking him to a hospital in rural Durango, Colorado.
Cannon boarded American Airlines (AAL) Flight 1444 from Louisville to Dallas-Fort Worth on April 28 at around 12:30pm.
He collapsed while deplaning in Dallas and was 'helped to the floor of the jet bridge', the complaint states.
'Two minutes and fifteen seconds later, John was released to make his connecting flight,' the lawsuit adds. 'While Mr. Cannon exhibited concerning signs of medical distress, AAL personnel proceeded to transfer him to his connecting flight.'
He flew from Dallas to Durango onboard Flight 4896, but allegedly fell unconscious 'during the flight, and/or at the time of de-boarding.'
The complaint, which does not note the exact time the flight landed, states that crew called emergency services at 4:04pm to report Cannon's deteriorating condition, allegedly after the deplaning process was complete.
Firefighters rushed to the scene and gave Cannon an 'oxygen treatment' before removing him from the aircraft with the help of paramedics, according to the suit.
He was taken to Durango's Mercy Medical Center in an ambulance, but suffered a 'sinus bradycardia' - a heart rhythm where your heart beats slower than expected - during transport, which progressed to cardiac arrest.
'The ambulance crew performed approximately 10 minutes of chest compression, administered two doses of epinephrine, and delivered multiple Automated External Defibrillator (AED) shocks,' the complaint states.
But despite paramedics' best efforts, he did not resume a sustained heart rhythm and effective blood flow, and was pronounced dead the next morning at 1:29am.
The lawsuit - initially filed in Denver County District Court, but removed to Denver federal court Tuesday - accuses American Airlines of negligent delay in medical aid, failure to deny boarding in Dallas, neglect in first aid delivery, and medical triage negligence.
It alleges that crew did not pay appropriate attention to Cannon's condition, failed to prioritize his needs, and did not take reasonable steps to get him to the care of a physician in a timely manner.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kourtney Kardashian indulges in a cheat day… after her secret weight loss trick revealed
Kourtney Kardashian indulges in a cheat day… after her secret weight loss trick revealed

Daily Mail​

time5 days ago

  • Daily Mail​

Kourtney Kardashian indulges in a cheat day… after her secret weight loss trick revealed

Kourtney Kardashian indulged in a cheat day, just days after flaunting her incredible bikini body. The reality star, 46, shared a snap of her delicious breakfast - which appeared to be pancakes with strawberries, syrup and a creamy sauce. Kourtney enjoyed a weekend in La Jolla, California with her husband Travis Barker, drummer of Blink-182. She revealed the reason why they were in the San Diego neighborhood via her stories - with a snap of Travis' half marathon medal. Last week, Kourtney flaunted her incredible body in a tiny string bikini while soaking up the sun on a boat. This comes just after has learned that Kourtney has shed the pregnancy pounds by taking a weight loss supplement. It's her very own GLP-1 Daily support and weight management supplement from her brand Lemme. It can cost $2 a day if bought in the six-month package for $336. 'She takes her own pills and they work because they curb the appetite, especially when it comes to sweets,' said an insider. 'And it is all natural, no weird ingredients. She loves all her products because they work and there are no side effects.' The Daily Mail has not received a response to its request for comment from her representative. The ingredients of Lemme GLP-1 Daily are: Eriomin Lemon Fruit Extract: A patented ingredient that supports GLP-1 production; Supresa Saffron Extract: A clinically-studied ingredient that helps reduce hunger and cravings; Morosil Red Orange Fruit Extract: A patented ingredient that supports weight management. Other ingredients may include: Chromium, Vitamin B12, Gymnema Sylvestre Leaf Extract, and Phytonutrient Fruit Complex. Days prior, she shared a red bikini top image. The KUWTK alum uploaded a slideshow to Instagram that featured a sexy bikini selfie as well as glimpses into her home life with husband Travis Barker, 49. In another shot, Kourtney rocked a 'Travis' T-shirt and flashed her massive diamond wedding ring as she snapped a photo of herself in a Rolls-Royce. Kourtney's 'long weekend' also consisted of a cruise around Calabasas with Travis in his vintage Chevrolet truck. She even shared an up-close look at the vehicle's custom interior featuring plaid orange upholstery. The star — who rose to fame alongside her family on Keeping Up with the Kardashians — made sure to add various outtakes from her luxurious, sprawling mansion in Calabasas. There was an artistic shot of what appeared to be her and Travis' bedroom with fluffy white bedding and a framed black and white piece of art. Kourtney went on to post a scenic photo of her huge backyard pool overlooking mountains. Also included in the slideshow was a photo of what appeared her and Travis' one-year-old son Rocky's scooter sitting idly in the hallway of their home. It comes after Kourtney made drastic updates to her home to fit her and Travis' blended family. Kourtney shares Mason, 15, Penelope, 12, and Reign, 10, with ex-boyfriend Scott. Travis is stepdad to Atiana De La Hoya, 26, son Landon, 21, and daughter Alabama, 19, with ex-wife Shanna Moakler, 50. The husband and wife, who married in Italy in May 2022, were neighbors and friends for 10 years before striking up a romance. They continued to live in their respective homes, minutes apart, even after tying the knot, until their son Rocky was born in late 2023. While things at home with Travis may be peaceful, a source recently dished to that Kourtney and Scott are at odds over co-parenting. Rumors of a co-parenting war between the exes kicked off last week after Kourtney sparked fury after she discussed her controversial approach to parenting with her sister Khloe Kardashian for an interview on her podcast, Khloe in Wonder Land. Kourtney opened up about not conforming to what's expected of a family as she claimed her children want to be homeschooled. Fans branded her 'out of touch' and harshly accused her of being the 'dumbest of the sisters.' 'Why do kids f*****g go to school?' Kourtney asked, adding that it is a 'dated' practice. The comments infuriated Scott, 42, who found them 'irresponsible,' according to sources, who claim he is struggling to recognize his ex of late. 'Scott strongly disagrees with Kourtney's parenting style and finds her comments irresponsible,' one insider told 'Scott values hard work and sees school as essential and would never allow his kids to not attend.' Kourtney was one of the only Kardashian sisters to attend college. She started her bachelor's degree at the traditional Southern Methodist University in Texas before graduating from the party school University of Arizona. But she's made it clear that she no longer believes attending school in person is important. Scott, who 'feels Kourtney has changed,' will have his children homeschooled 'over his dead body.' The father-of-three, who still appears on the family reality show, is also said to have issues with the influence of Kourtney's step-children. 'Life at Kourtney and Travis' house can be chaotic and Scott is especially uneasy with the influence of Travis' daughter, Alabama,' the source said. 'He makes clear that while Travis may be Rocky's dad, he will never be a father to his kids.'

Record deal with jab-maker BioNTech could see UK become science 'superpower'
Record deal with jab-maker BioNTech could see UK become science 'superpower'

Daily Mirror

time20-05-2025

  • Daily Mirror

Record deal with jab-maker BioNTech could see UK become science 'superpower'

Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and prevent cancers before they develop Britain could become the global 'superpower' at treating disease, the Government says. The UK will today sign a new billion pound deal with drugmaker BioNTech to pioneer mRNA technology to fight the next pandemic and prevent cancers. The Covid jab-maker is investing £1 billion to set up three centres of excellence in the UK which will also use artificial intelligence (AI) to develop new drugs here for a range of diseases. ‌ Science and Technology Secretary Peter Kyle told the Mirror: 'There are two totally transformative technologies coming together - mRNA as a tool for vaccines plus artificial intelligence. We as a country can be not just a leading force, but the superpower that the world needs when it comes to treating disease.' ‌ BioNTech, in collaboration with Pfizer, was the first company to develop an mRNA vaccine against Covid-19, which became the main vaccine used in Britain during the pandemic. Traditionally, vaccines inject a weakened or deactivated form of a virus to help the body's immune system recognise it so that when it comes into contact with a genuine infection it can fight it off. The mRNA technology does not use any virus but instead delivers genetic instructions to train the immune system to identify the virus's spike protein. This meant it was deemed to be safer and less likely to cause side effects. The same technology is now being used to develop cancer vaccines which help the body recognise and kill cancer cells. They could even be given to people at genetic risk of specific cancers to prevent tumour developing. Mr Kyle said: 'The Holy Grail is always stopping people getting cancer in the first place and mRNA treatments are preventative. We are in the foothills of the age where we could be treated for diseases that are not currently present in our bodies and actually the technology is leading in that direction faster than people realise. This is something that this government wants to be at the forefront of so it is British people who benefit first, while we also contribute to the global good.' ‌ BioNTech is aiming to provide 10,000 UK patients with personalised cancer immunotherapies, tailored to their individual genetic risk, by 2030. It comes after the previous government signed a ten-year deal with the other big mRNA pharmaceutical firm Moderna in 2022, which last week opened its new manufacturing lab in Oxfordshire. German multinational BioNTech will now start work setting up centres of excellence in Cambridge, London and a yet-to-be-confirmed third location. The London site will be a major hub to research AI to enhance our understanding of diseases, their causes and how drugs could target them. ‌ Mr Kyle said: 'This is a foundational technology that could be applied in ways that we can't even imagine right now. AI knows everything. It has consumed every scientific experiment in certain areas that has ever taken place and it can bring all of that information to bear. That means that its ability to solve problems using patterns and ideas using potential chemicals or existing drugs… is infinite. 'Imagine computer programs that actually have almost all information in it and are able to harness it and throw this information at new challenges. Then you get a glimpse of the era that we are now stepping into as humanity. How exciting it should be, and how much pride we should all take, that Britain is leading the way.' How does mRNA work? (by Health and Science Editor Martin Bagot) Messenger RNA (mRNA) has been described as a bit like developing a wanted poster for our immune system. Britain has made a huge investment in mRNA capabilities to protect the population from future pandemic and better treat existing diseases. ‌ It uses genetic code to create an immune response by giving the body the instructions to protect against a certain virus or disease. Such vaccines have the potential to be repurposed at speed when combined with the vast genetic knowledge which can be harnessed by AI. Once the design has been proven then a different face to the wanted poster - or a different set of genetic instructions - can be slotted in easily. Vaccines which help prime the body's immune system to stop cancers returning are already here. The next step will be to develop personalised vaccines for people at high genetic risk of cancer to stop it developing in the first place. ‌ At a third site, to be announced shortly, BioNTech will research vaccines including for diseases with high pandemic potential. To help get the deal with BioNTech the Government agreed to contribute £129 million in grant funding over the next ten years. The UK life sciences sector is worth over £100 billion in turnover annually in the UK and supports 304,000 jobs in 6,850 businesses. ‌ Chancellor Rachel Reeves said:'This is another testament to confidence in Britain being one of the world's top investment destinations and a global hub for life sciences. It will create hundreds of high-skilled, well-paid jobs, as we deliver on our promise to put more money in working people's pockets through our Plan for Change.' BioNTech co-founder Uğur Şahin said: 'This agreement marks the next chapter of our successful strategic partnership with the UK Government. Together, we have already made a meaningful difference in expanding access to investigational personalized cancer therapies for patients. Now we are taking the next step to accelerate and broaden our research and development efforts advancing towards our vision to translate science into survival for patients.' Steve Bates, CEO of the UK BioIndustry Association, said: 'BioNTech's investment demonstrates the UK's position as a top destination for life sciences innovation and underlines why the government is absolutely right to back our sector as a priority for growth. BioNTech is not only a pioneer in mRNA science, but also a visionary partner in building a truly unique public-private collaboration with the UK Government and NHS – one that sets a benchmark for the world. ‌ 'The UK has a once-in-a-lifetime opportunity to leverage its strong position to attract investment from global investors to create well-paid jobs and scale UK companies, if the upcoming Life Sciences Sector Plan can address long-standing structural challenges in the financing and commercial environment.' Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), said: 'This investment is a testament to the fantastic skills, research capabilities, and scientific infrastructure we have in the UK. It is also a template for how the UK could unlock further life science sector growth by removing the barriers and roadblocks to investment. 'Big investments like this are years in the making and require both sides to have confidence that the other will deliver on their commitments. Trust is slow to build, but this deal shows it is worth the time and the risk. 'Life science companies are already the largest investors in UK R&D – but much of this comes from a handful of companies with deep UK roots. The UK has an opportunity to capture more of the global science pie if we can improve our competitive offering to the sector.'

Ingredient linked to DEMENTIA found in popular food product used by over 200m Americans
Ingredient linked to DEMENTIA found in popular food product used by over 200m Americans

Daily Mail​

time20-05-2025

  • Daily Mail​

Ingredient linked to DEMENTIA found in popular food product used by over 200m Americans

Ziploc, the popular brand of food bags and containers used by over 200 million Americans, is now at the center of a troubling health controversy. A class-action lawsuit filed in California accuses the maker of Ziploc, of misleading consumers about the safety of its microwave-safe bags and containers. The complaint alleges that the plastic in Ziploc products may release harmful microplastics , potentially exposing millions to toxins over time. Microplastics are tiny plastic fragments —less than 5 millimeters in size—linked to cancer, cardiovascular disease, and reproductive problems. These particles can enter our food, water, and even the air as plastic products break down. The 51-page lawsuit claims that Ziploc bags and containers, marketed as 'Microwave Safe' and suitable for freezer use, fail to warn consumers that the products may release microplastics when used as intended. The complaint specifically mentions Ziploc Freezer Bags, Slider Freezer Bags, Slider Storage Bags, and Ziploc Containers. 'The 'Microwave Safe' and 'Freezer' labels create a false sense of security,' the lawsuit states. 'The company omits crucial information that these products release microplastics when microwaved or frozen as directed.' has contacted S.C. Johnson for comment. The lawsuit argues that this omission isn't just misleading, but it means the products fail at their basic purpose. 'The products fail to provide a reliable method for food storage and preparation without exposing users to material risk,' the complaint states. Filed by California resident Linda Cheslow, the suit claims that the containers labeled 'Microwave Safe' and 'Freezer' are made from polyethylene and polypropylene. Polyethylene and polypropylene are common types of plastic that can break down into microplastics, and both are used in food packaging. 'Scientific and medical evidence shows these materials release microplastics when microwaved or frozen—making them fundamentally unsafe for those uses,' the lawsuit claims. 'Because of the defendant's false claims, people have unknowingly exposed themselves and their families to harmful microplastics during everyday kitchen activities.' The lawsuit accuses S.C. Johnson of violating consumer trust by marketing food-safe containers while hiding known health risks. 'The company exploits consumer expectations by failing to disclose that its products release microplastics into food when microwaved or frozen,' the complaint adds. It also claims that Ziploc bags labeled 'Microwave Safe' can release up to 4.22 million microplastic and 2.11 billion nanoplastic particles per square centimeter of plastic within just three minutes of microwave heating. The 'Freezer' label, the suit says, misleads consumers into thinking the products are safe for low-temperature food storage without risk. The complaint further cites studies showing a 50 percent increase in microplastics found in brain samples from 2016 to 2024, suggesting these particles accumulate in the body over time. Polypropylene microplastics were also found in bone marrow, indicating they can penetrate deep into human tissues. Scientists found that human brain samples contained between seven and 30 times more microplastics than livers or kidneys, with higher levels reported in individuals with dementia. Both liver and brain samples from 2024 showed significantly more microplastics than those from 2016. S.C. Johnson responded with a statement denying the allegations: 'We believe Ziploc products are safe when used as directed and that these claims are without merit.' Rubbermaid, another major brand named in related concerns, is also facing criticism as toxicologists highlight issues with heat-related plastic breakdown and chemical leakage. In the lawsuit against S.C. Johnson, the plaintiff argues that the class should include all consumers nationwide who purchased the products within the statute of limitations. The complaint requests that the last four years be used to define this period for California consumers. Plastic food containers have long been popular in American homes because they are affordable, convenient, and durable. However, public opinion is shifting as more research links plastic exposure to serious health risks. Class members who join the lawsuit are eligible to receive an equal share of any settlement. There is growing pressure on the Food and Drug Administration to update its standards for microwave-safe labeling. Critics say current regulations are outdated and don't adequately address long-term chemical exposure or how these products are actually used.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store